Found: 24
Select item for more details and to access through your institution.
Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1562-7
- By:
- Publication type:
- Article
A case of otitis media with ANCA-associated vasculitis accompanied with pituitary mass successfully treated by corticosteroids.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
- Published in:
- Scientific Reports, 2016, p. 38684, doi. 10.1038/srep38684
- By:
- Publication type:
- Article
Subclinical inflammation with tocilizumab treatment of rheumatoid arthritis: MRI evaluation for 2 years.
- Published in:
- International Journal of Rheumatic Diseases, 2015, v. 18, n. 1, p. 108, doi. 10.1111/1756-185X.12460
- By:
- Publication type:
- Article
Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 5, p. 1181, doi. 10.1007/s10067-015-3082-z
- By:
- Publication type:
- Article
A case of relapsing neurosarcoidosis with brain nodules and hydrocephalus successfully treated by corticosteroid and methotrexate.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Clinical vignette.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Involvement of CD161+ Vδ1+ γδ T cells in systemic sclerosis: association with interstitial pneumonia.
- Published in:
- Rheumatology, 2014, v. 53, n. 12, p. 2259, doi. 10.1093/rheumatology/keu246
- By:
- Publication type:
- Article
CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8483, doi. 10.1038/ncomms9483
- By:
- Publication type:
- Article
Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease.
- Published in:
- International Journal of Rheumatology, 2012, p. 1, doi. 10.1155/2012/580814
- By:
- Publication type:
- Article
Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
- Published in:
- Modern Rheumatology, 2019, v. 29, n. 6, p. 964, doi. 10.1080/14397595.2018.1532545
- By:
- Publication type:
- Article
Anti-cyclic citrullinated glucose-6-phosphate isomerase peptide-7 (CCG-7) antibodies were suppressed by biologics treatment and deposited to citrullinated proteins in CD68-positive cells in the RA synovium.
- Published in:
- Modern Rheumatology, 2017, v. 27, n. 5, p. 914, doi. 10.1080/14397595.2016.1270388
- By:
- Publication type:
- Article
Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy) trial
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 6, p. 891, doi. 10.3109/14397595.2016.1158773
- By:
- Publication type:
- Article
Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 6, p. 857, doi. 10.3109/14397595.2016.1153567
- By:
- Publication type:
- Article
Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.
- Published in:
- Modern Rheumatology, 2016, v. 26, n. 1, p. 29, doi. 10.3109/14397595.2015.1069471
- By:
- Publication type:
- Article
Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeks
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 2, p. 187, doi. 10.3109/14397595.2014.951144
- By:
- Publication type:
- Article
Clinical features of patients with IgG4-related disease complicated with perivascular lesions.
- Published in:
- Modern Rheumatology, 2015, v. 25, n. 1, p. 105, doi. 10.3109/14397595.2014.903596
- By:
- Publication type:
- Article
Clinicopathological features of IgG4-related disease complicated with orbital involvement.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 3, p. 471, doi. 10.3109/14397595.2013.844307
- By:
- Publication type:
- Article
Analysis of subclinical synovitis detected by ultrasonography and low-field magnetic resonance imaging in patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2014, v. 24, n. 1, p. 60, doi. 10.3109/14397595.2013.854050
- By:
- Publication type:
- Article
Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
- Published in:
- Modern Rheumatology, 2013, v. 23, n. 4, p. 782, doi. 10.3109/s10165-012-0746-2
- By:
- Publication type:
- Article
Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis.
- Published in:
- Modern Rheumatology, 2012, v. 22, n. 1, p. 128, doi. 10.3109/s10165-011-0475-y
- By:
- Publication type:
- Article
Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
- Published in:
- Modern Rheumatology, 2011, v. 21, n. 3, p. 267, doi. 10.3109/s10165-010-0392-5
- By:
- Publication type:
- Article
Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximab.
- Published in:
- Modern Rheumatology, 2009, v. 19, n. 3, p. 229, doi. 10.3109/s10165-009-0162-4
- By:
- Publication type:
- Article